InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-51.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by HANISH ARNOLD C, Director. Insider active across 3 companies, notably Salarius Pharmaceuticals, Inc.. Cumulatively, 10 reports have been recorded. Split: 6 buys · 0 sell. Total volume traded: €33k. Activity tracked since 10 August 2021. The latest transaction was disclosed on 22 May 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
5,000 shares@ US$5.3013.3% of flowCommon StockSEC:0001415889-23-008651:0
1,440 shares0Common StockSEC:0001615219-23-000011:0
4,350 shares@ US$1.1513.9% of flowCommon StockSEC:0001615219-22-000091:0
Ideal exit: 7 Nov 2020 (T+270)
28,000 shares@ US$0.18414.5% of flowCommon StockSEC:0001615219-22-000095:0
Ideal exit: 28 Feb 2023 (T+270)
4,000 shares@ US$0.9810.0% of flowCommon StockSEC:0001615219-22-000093:0
Ideal exit: 18 May 2021 (T+270)
3,000 shares@ US$3.5929.6% of flowCommon StockSEC:0001615219-22-000089:0
Ideal exit: 21 Aug 2020 (T+270)
10,000 shares@ US$9.440.0090% mcap50.0% of flowCommon StockSEC:0001415889-21-004308:0
10,000 shares@ US$9.4443.3% of flowCommon StockSEC:0001415889-21-004308
7,000 shares@ US$0.88116.0% of flowCommon StockSEC:0001615219-21-000085
Ideal exit: 7 May 2022 (T+270)
7,000 shares@ US$0.88116.0% of flowCommon StockSEC:0001615219-21-000085:0
Ideal exit: 7 May 2022 (T+270)
10 of 10 declarations
About HANISH ARNOLD C
HANISH ARNOLD C serves as a Director at Salarius Pharmaceuticals, Inc. and OMEROS CORP. He contributes to the governance and strategy of these companies. His experience is valuable in guiding direction and ensuring compliance.
